Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others.
The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2028
Request For A Sample Of The Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Report: https://www.coherentmarketinsights.com/insight/request-sample/3721
Market Drivers:
Growing number of surgical procedures is projected to augment growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. According to ‘Surgical operations and procedures statistics’ of Eurostat in November 2019, at least 1.4 million caesarean sections performed in the EU in 2017.
Moreover, growing incidence of early postoperative small bowel obstruction is agaibn expected to support growth of the market. For instance, according to the study, “Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications”, published in the American Journal of Obstetrics and Gynecology, in March 2019, the incidence rate of early small bowel obstructions was 5.9 per 1000 hysterectomies and 43.7% of the study population developed small bowel obstruction during the initial hospital stay and 23.1% underwent reoperation.
Increasing number of cardiovascular procedures is projected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.
Statistics:
Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3721
Market Restraints:
Launch of a single new product of hemostat, tissue sealant or adhesion barriers in the market costs tremendous investment and long duration. For instance, time involved in the clinical and pre-clinical trials for these products is as high as 10 years or more.
Strict federal approval procedures for new products are exerting significant difficulties for market development. Furthermore, some surgical sealants demonstrate less glue quality and have restricted applications. Such scenario also limits growth of the market.
Market Opportunities:
There is a high incidence of injuries and burns which is projected to provide lucrative growth opportunities for players in the market. According to the World Health Organization’s March 2018 key facts, an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries.
Application of bone glue, tissue sealants & bio sealants helps reduce cross-contamination, supporting healing process, and decreases blood loss owing to surgical stiches and staplers and improves quality of patient care. Growing awareness among physicians about benefits such as reduced cost of post-surgical complications treatment and reduced hospital stay post-surgery due to faster healing and recovery of surgical wounds is also projected to support growth of the market.
Market Trends/Key Takeaways
Rise in prevalence of cardiovascular disease (CVD) is projected to boost growth of the market in North America. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, CVD was responsible for 840,768 deaths (635,260 cardiac) in 2016 in the U.S.
Growing number of surgical procedures is expected to support growth of the market in Asia Pacific. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.
Competitive Landscape:
Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring.
Market Key Developments:
Major players are focused on introducing new products to expand their product portfolio. For instance, in March 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched SURGICEL POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.
Major players are also focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Baxter International Inc. competed acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi.
Reasons to Buy this Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market
➡Leading company profiles reveal details of key Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
https://www.coherentmarketinsights.com/insight/buy-now/3721
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Impact
Chapter 2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Competition by Types, Applications, and Top Regions and Countries
2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers (Volume and Value) by Type
2.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales, Consumption, Export, Import by Regions
Chapter 5 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 6 East Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 7 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 8 South Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 9 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 10 Middle East Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 11 Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 12 Oceania Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 13 South America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
Chapter 14 Company Profiles and Key Figures in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business
Chapter 15 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837